down arrow

Oxygenta Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE102E01018
  • NSEID:
  • BSEID: 524636
INR
77.00
-1 (-1.28%)
BSENSE

Apr 11, 12:48 PM

BSE+NSE Vol: 1.79 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Oxygenta Pharmaceutical Ltd stock-summary
stock-summary
Oxygenta Pharmaceutical Ltd
Micro Cap
Pharmaceuticals & Drugs
Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals. Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 2021-22.
Company Coordinates stock-summary
Company Details
Survey No 252/1 Aroor Village, Sadasivapet Mandal Medak Telangana : 502291
stock-summary
Tel: 91-08455-250080/250280
stock-summary
http://oxygentapharma.com
stock-summary
info@ssorganics.co.in
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 35.48 Cr
Number of Shares
3.55 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
21-May-2024
3.55
35.48
2000000
10
Preferential basis
03-May-2023
3.35
33.48
19282200
10
Warrant Conversion/Pref.allotment
30-Sep-2021
1.42
14.20
4000000
10
As Per Shareholding Pattern
30-Sep-2021
1.42
14.20
4000000
10
As Per Shareholding Pattern
12-Aug-2021
1.42
14.20
4000000
10
Preferential basis
01-Apr-2009
1.02
10.20
2500000
10
Conversion of Debt
01-Apr-2009
1.02
10.20
2500000
10
Conversion of Debt
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 3 Schemes (0.03%)

FIIs

Held by 0 FIIs

Promoter with highest holding

M V S Prasad Reddy (25.56%)

Highest Public shareholder

Sravani Reddy Gantla (12.13%)

Individual Investors Holdings

43.92%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Sai Sudhakar Vankineni
Managing Director
12.0 lacs
D Vidya Sagar
Independent Director
0
Muralidhar R
Director (Technical)
0
Sangari Kondal Reddy
Independent Director
0
Padmaja Surapureddy
Independent Director
0
Kanuganti Raghavender Rao
Executive Director
0
Sravani Reddy Gantla
Additional Director
0
Bharath Reddy Guntuku
Additional Director
0
Dolly Mandhan
Company Sec. & Compli. Officer
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Jobwork Income
2.76
33.89%
 
33.89
Jobwork Income
66.11
Jobwork Income
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
33 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-4 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 289 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-2.84

stock-summary
Return on Equity

1.84%

stock-summary
Price to Book

-14.33

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."